The Renal Papilla
Authors: Jessica Vanslambrouck, Joan Li, Melissa H. Little
Journal: Journal of the American Society of Nephrology (2011)

It is now well established that organ-specific adult stem cells exist in a variety of tissues throughout the body where their survival, proliferation, and multipotency are regulated by the niche in which they reside. The controversy over whether such populations also exists in a relatively nonproliferative, nonregenerative organ such as the kidney has been the topic of debate for almost a decade.1 A variety of interstitial and epithelial populations have been identified as potential renal stem cells based on location, stem cell marker expression, or functional properties such as Hoechst-dye efflux. Considerable focus has been directed toward the renal papilla as a putative stem cell niche based on the observation of long-term label retaining cells in the papilla after bromodeoxyuridine (BrdU) injection around birth in the mouse. However, the prospective isolation of this enigmatic papillary stem cell population has proven problematic, and their identity and in vivo properties remain elusive and controversial. In this issue of JASN, Song et al. investigate mTert as a potential marker for this population.2 Somewhat inadvertently, their findings lead us to revisit papillary development and response to injury, highlighting our lack of understanding of this unique cellular compartment. The papilla, or inner medulla, lies in the center of the adult kidney protruding into the pelvis. The collecting ducts pass through the papilla providing a conduit for the urinary filtrate to reach the ureter. The loops of Henle extend down into the papilla, and it is the length of these tubules that determines urinary concentrating capacity. At birth, the papilla is very short and contained within the pelvis. During the immediate postnatal period, this region undergoes extensive elongation to form a final structure that protrudes out of the kidney along the existing ureter. Although an abundant literature exists pertaining to the out-budding and branching of the ureteric bud that forms the collecting ducts, the literature is relatively silent on the process of papillary elongation and maturation. A number of studies implicate the papilla as a potential stem cell niche. Certainly, the environment around the cells of the papilla differs markedly from that of its surrounding tissue, being both hyperosmotic and hypoxic. This is in some ways reminiscent of niche microenvironments harboring stem cells in other organs, such as bone marrow and brain, where hypoxia is thought to play a role in stem cell maintenance and protection against DNA damage.3 When cultured in vitro, a portion of papillary cells form spheres that coexpress mesenchymal and epithelial markers,4 a behavior arguably reminiscent of neurosphere formation by neural stem cells. Furthermore, genetic labeling techniques (using BrdU and transgenic mice possessing doxycycline-inducible expression of green fluorescent protein [GFP] fused to histone 2B) indicate the presence of slow-cycling populations of label retaining cells (LRCs) in rodent kidney, predominately located in the papilla.4,5 These papillary LRCs are found in the interstitium as well as incorporated into collecting ducts of the papilla and are proposed to be stem cells.5 Based on the observation that LRCs from the papilla migrate toward the cortical region in response to injury, a role for these cells is predicted not only in homeostasis of the papilla, but also in renal repair. A number of additional features lends further support to the concept that these cells are stem cells. Similar to other organ-specific stem cells, the interstitial LRCs are in close association with endothelial cells. When analyzed for marker expression, the LRCs express nestin, a marker of stem and progenitor cells first identified in neuroepithelial cells, and the somatic stem cell marker, prominin/CD133. Interestingly, similar CD133+ nestin+ cells have also been identified in the human papilla.6 Here these cells are enriched in the loops of Henle of the renal medulla and papilla, coexpress embryonic and stem-related genes, and are capable of forming epithelial tubular structures in vitro. Despite this substantial body of evidence in support of papillary stem cells, prospective isolation of this population has not been achieved. Hence, it has not been possible to validate clonogenicity or fully characterize the origin or potential of such cells. Consequently, there remains no proof that a stem cell population exists. In this issue, Song et al.2 adopt a marker-based approach in their continued efforts to identify a papillary stem cell population. Founded on evidence that telomerase (mTert) marks stem cells of other embryonic and adult tissues,7 their study seeks to characterize the telomerase (mTert)+ population of the renal papilla. Song et al.2 identify a subset of papillary epithelial cells that show strong expression of telomerase, approximately 5% of which are BrdU label-retaining cells. A more minor fraction of these cells is present in the papillary interstitium. However, fate tracing of telomerase-expressing cells postischemic injury using an mTert-GFP reporter mouse shows that these cells do not proliferate, migrate, or play any role in tubular repair. The concept that cells from the papilla migrate into the cortex to contribute to tubular repair contrasts with the favored model that involves the proliferation of surviving terminally differentiated epithelial cells.8 In agreement with the more traditional model, lineage-tracing studies show no evidence for the involvement of non-epithelial-derived cells in tubular repair,8 casting doubt on contributions from migrating papillary cells. Subsequent fate-mapping studies confirms the presence of an LRC population in the papilla, but shows no evidence for migration to the site of injury.9 Song et al., 2 while investigating mTert as a possible marker of papillary stem cells, also show no evidence for migration of mTert+ LRCs from the papilla in response to injury. However, not all papillary LRCs are mTert+, and so a distinct subset of papillary LRCs may have migratory capacity. Other reports, utilizing alternative markers, have independently provided evidence for an interstitial migratory cell population during renal injury. In a model of fetal urinary obstruction in the primate, a CAII+ αSMA+ population of cells was shown to arise from the collecting ducts and migrate into the interstitium of the obstructed kidney through epithelial-mesenchymal transition.10 Whether these cells represent the migrating LRCs originally observed by Oliver et al.4,5 is not known. The initial observation of a LRC population in the kidney need not necessarily represent a stem cell population. It is also possible that LRCs within the papilla represent a population that enters quiescence close to birth. This concept has been investigated through pulse labeling at different time points.11 By embryonic day 17.5, little proliferation remains in the distal papilla (away from the medulla), whereas proliferation is more evident in other regions of the kidney.11 By late gestation, epithelial proliferation appears restricted to the proximal papilla (closest to the medulla). Indeed, excessive collecting duct proliferation results in obstruction,12 suggesting that cell cycle arrest is important for the development of normal physiological functions within the papilla. If proliferation within the papilla ends around birth, LRCs would not be detected in this region if the BrdU was administered after this point in time. This is evident when BrdU is delivered after birth, resulting in LRCs restricted to the proximal tubules and not the papillary interstitium.13 The data of Song et al. also provide little evidence for papillary proliferation,2 again raising the question of how this region can undergo such extensive elongation in the immediate postnatal period and how it can respond to injury. Cell cycle arrest in the collecting duct epithelium has been proposed in response to the extremes of osmolarity and oxygen tension present in this region of the kidney. The majority of cells in the collecting duct arrest in G0/G1 and induce the expression of p53 and chaperones, including Hsp70, rendering these cells resistant to apoptosis.14,15 As a result of these adaptations, cells of the papilla appear more resistant than the cortical epithelia to injury. mTert null mice show an increased sensitivity to renal injury that had been attributed to critically shortened telomeres, decreased proliferation, increased p21 expression, and increased apoptosis throughout the kidney.16 Although this may be the case, it is unlikely that this represents the response of the mTert+ cells within the papilla, which already appear to be relatively nonproliferative. Song et al. do show that mTert expression is upregulated in response to injury, although this does not trigger cell division or migration.2 In conclusion, this most recent study rules out a role for mTert+ cells in the papilla as stem cells responsible for injury-induced repair, leaving open the question of whether there is a stem cell in this region. Although consistent with the concept that there is no stem cell involved in renal tubular repair, this study fails to explain the apparent resistance of this compartment to injury. Given that all of the filtration units drain through the collecting duct epithelium of the papilla, loss or damage to this portion of the epithelial network would be catastrophic for renal function. Hence, this plumbing is likely to have evolved a robust response to a variety of damage signals. Understanding the mechanism of this response may prove invaluable in modulating responses to injury throughout this organ. DISCLOSURES M. H. L. is a Principal Research Fellow of the National Health and Medical Research Council, Australia.